BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35902498)

  • 1. ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
    Bayard S; Bea VJ
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):599. PubMed ID: 35902498
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections on "Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center".
    Zaveri S; Romanoff A
    Ann Surg Oncol; 2022 Oct; 29(11):6704. PubMed ID: 35731359
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Racial and Socioeconomic Disparities in Breast Cancer Mortality Persist Beyond Tumor Biology.
    Kantor O; Mittendorf EA
    Ann Surg Oncol; 2022 Jan; 29(1):697-698. PubMed ID: 34403007
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Delays in Breast Cancer Treatment During the COVID Pandemic-Disparities in Delay and a Call to Action.
    Chung SH; Sachs TE
    Ann Surg Oncol; 2023 Oct; 30(10):6106-6107. PubMed ID: 37434072
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Addressing Racial Disparities in Pancreatic Cancer: How Can We Do Better?
    Anteby R; Qadan M
    Ann Surg Oncol; 2023 Apr; 30(4):2482-2483. PubMed ID: 36652023
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays.
    Schermerhorn MC; Grunvald MW; O'Donoghue CM; Rao RD; Becerra AZ
    Ann Surg Oncol; 2022 Nov; 29(12):7659-7660. PubMed ID: 35789306
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: A Call to Modify Factors Predictive of Noncompliance with Quality Measures in Breast Cancer Treatment.
    Zheleva V; Lai LL
    Ann Surg Oncol; 2020 Aug; 27(8):2626-2627. PubMed ID: 32236743
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Improving Efficiency of Care for Young Women with Breast Cancer.
    Cordeiro E; Guay E; Roberts A
    Ann Surg Oncol; 2022 Apr; 29(4):2261. PubMed ID: 34981247
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: How COVID-19 Impacted Breast Cancer Presentation and Management.
    Tonneson JE; Boughey JC
    Ann Surg Oncol; 2022 Apr; 29(4):2240-2241. PubMed ID: 34850303
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population.
    Thalji SZ; Cortina CS; Kong AL
    Ann Surg Oncol; 2023 Oct; 30(11):6471-6472. PubMed ID: 37368097
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Changes in Breast Cancer Management with Advances in Tumor Biology Over Time.
    Ong C; Blue CM; McGuire KP
    Ann Surg Oncol; 2024 Feb; 31(2):1003-1004. PubMed ID: 37857984
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Translational Epidemiology in Breast Cancer Research: Integrating Social and Biological Data to Understand Disparities.
    Hernandez AE; Goel N
    Ann Surg Oncol; 2024 Mar; 31(3):1656-1657. PubMed ID: 38071718
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Using the Cancer Genome Atlas to Investigate the Role of Genetics in Breast Cancer Disparities.
    Johnson JA; Newman LA
    Ann Surg Oncol; 2024 Feb; 31(2):999-1000. PubMed ID: 37968410
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
    Schermerhorn MC; Grunvald MW; O'Donoghue CM; Rao RD; Becerra AZ
    Ann Surg Oncol; 2022 Nov; 29(12):7652-7658. PubMed ID: 35751007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment.
    Lim DW; Metcalfe KA
    Ann Surg Oncol; 2021 Oct; 28(11):5999-6000. PubMed ID: 33950312
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients.
    Shelton C; Nielsen SM
    Ann Surg Oncol; 2024 Feb; 31(2):1007. PubMed ID: 37996642
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Time to Treatment: A New Quality Metric in Breast Cancer Care?
    Pratt D; Grobmyer SR
    Ann Surg Oncol; 2021 Dec; 28(13):8609. PubMed ID: 34050427
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers.
    Saridakis A; Berger ER; Greenup R; Golshan M; Lannin DR
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):581-582. PubMed ID: 34743280
    [No Abstract]   [Full Text] [Related]  

  • 19. Deconstructing Racial and Ethnic Disparities in Breast Cancer.
    Sparano JA; Brawley OW
    JAMA Oncol; 2021 Mar; 7(3):355-356. PubMed ID: 33475709
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: The Patient Perspective of Telemedicine in Breast Cancer Care.
    Johnson BA; Hui JYC
    Ann Surg Oncol; 2022 Jun; 29(6):3859-3860. PubMed ID: 34373966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.